146 related articles for article (PubMed ID: 36421692)
1. SRF Rearrangements in Soft Tissue Tumors with Muscle Differentiation.
Costa A; Gozzellino L; Urbini M; Indio V; Nannini M; Pantaleo MA; Stacchiotti S; Astolfi A; Pasquinelli G
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421692
[TBL] [Abstract][Full Text] [Related]
2. Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue.
Urbini M; Astolfi A; Indio V; Tarantino G; Serravalle S; Saponara M; Nannini M; Gronchi A; Fiore M; Maestro R; Brenca M; Dei Tos AP; Dagrada GP; Negri T; Pilotti S; Casali PG; Biasco G; Pession A; Stacchiotti S; Pantaleo MA
Oncotarget; 2017 Sep; 8(36):60036-60045. PubMed ID: 28947952
[TBL] [Abstract][Full Text] [Related]
3. Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation.
Antonescu CR; Sung YS; Zhang L; Agaram NP; Fletcher CD
Am J Surg Pathol; 2017 May; 41(5):677-684. PubMed ID: 28248815
[TBL] [Abstract][Full Text] [Related]
4. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
[TBL] [Abstract][Full Text] [Related]
5. Genetic variant of SRF-rearranged myofibroma with a misleading nuclear expression of STAT6 and STAT6 involvement as 3' fusion partner.
Nihous H; Macagno N; Baud-Massière J; Haffner A; Jouve JL; Gentet JC; Touzery C; Le Loarer F; Bouvier C
Virchows Arch; 2021 Mar; 478(3):597-603. PubMed ID: 32529351
[TBL] [Abstract][Full Text] [Related]
6. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.
Antonescu CR; Zhang L; Chang NE; Pawel BR; Travis W; Katabi N; Edelman M; Rosenberg AE; Nielsen GP; Dal Cin P; Fletcher CD
Genes Chromosomes Cancer; 2010 Dec; 49(12):1114-24. PubMed ID: 20815032
[TBL] [Abstract][Full Text] [Related]
7. SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin.
Li D; Niu Z; Yu W; Qian Y; Wang Q; Li Q; Yi Z; Luo J; Wu X; Wang Y; Schwartz RJ; Liu M
Nucleic Acids Res; 2009 Nov; 37(21):7059-71. PubMed ID: 19783823
[TBL] [Abstract][Full Text] [Related]
8. A novel EWSR1-VGLL1 gene fusion in a soft tissue malignant myoepithelial tumor.
Komatsu M; Kawamoto T; Kanzawa M; Kawakami Y; Hara H; Akisue T; Kuroda R; Nakamura H; Hokka D; Jimbo N; Itoh T; Hirose T
Genes Chromosomes Cancer; 2020 Apr; 59(4):249-254. PubMed ID: 31697442
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-664-5p promotes myoblast proliferation and inhibits myoblast differentiation by targeting serum response factor and
Cai R; Qimuge N; Ma M; Wang Y; Tang G; Zhang Q; Sun Y; Chen X; Yu T; Dong W; Yang G; Pang W
J Biol Chem; 2018 Dec; 293(50):19177-19190. PubMed ID: 30323063
[TBL] [Abstract][Full Text] [Related]
10. SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors.
Karanian M; Kelsey A; Paindavoine S; Duc A; Vanacker H; Hook L; Weinbreck N; Delfour C; Minard V; Baillard P; Blay JY; Pissaloux D; Tirode F
Am J Surg Pathol; 2020 Dec; 44(12):1725-1735. PubMed ID: 33021523
[TBL] [Abstract][Full Text] [Related]
11. Regulation of serum response factor activity and smooth muscle cell apoptosis by chromodomain helicase DNA-binding protein 8.
Rodenberg JM; Hoggatt AM; Chen M; Touw K; Jones R; Herring BP
Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1058-67. PubMed ID: 20739623
[TBL] [Abstract][Full Text] [Related]
12. A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements.
Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Fletcher CD; Antonescu CR
Genes Chromosomes Cancer; 2020 Jun; 59(6):348-356. PubMed ID: 31994243
[TBL] [Abstract][Full Text] [Related]
13. Novel SRF-ICA1L Fusions in Cellular Myoid Neoplasms With Potential For Malignant Behavior.
Suurmeijer AJ; Dickson BC; Swanson D; Sung YS; Zhang L; Antonescu CR
Am J Surg Pathol; 2020 Jan; 44(1):55-60. PubMed ID: 31478943
[TBL] [Abstract][Full Text] [Related]
14. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
15. The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF.
Philippar U; Schratt G; Dieterich C; Müller JM; Galgóczy P; Engel FB; Keating MT; Gertler F; Schüle R; Vingron M; Nordheim A
Mol Cell; 2004 Dec; 16(6):867-80. PubMed ID: 15610731
[TBL] [Abstract][Full Text] [Related]
16. Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing.
Chai J; Baatar D; Tarnawski A
Gastroenterology; 2004 Jun; 126(7):1809-18. PubMed ID: 15188176
[TBL] [Abstract][Full Text] [Related]
17. Pigmented (melanotic) myoepithelial tumor of soft tissue with EWSR1-KLF17 fusion.
Pižem J; Boštjančič E; Šekoranja D; Pleško J; Živec K
Cancer Genet; 2020 Aug; 246-247():48-52. PubMed ID: 32829130
[TBL] [Abstract][Full Text] [Related]
18. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
Cen B; Selvaraj A; Prywes R
J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
[TBL] [Abstract][Full Text] [Related]
19. Involvement of serum response factor isoforms in myofibroblast differentiation during bleomycin-induced lung injury.
Yang Y; Zhe X; Phan SH; Ullenbruch M; Schuger L
Am J Respir Cell Mol Biol; 2003 Nov; 29(5):583-90. PubMed ID: 12777247
[TBL] [Abstract][Full Text] [Related]
20. Serum response factor controls transcriptional network regulating epidermal function and hair follicle morphogenesis.
Lin C; Hindes A; Burns CJ; Koppel AC; Kiss A; Yin Y; Ma L; Blumenberg M; Khnykin D; Jahnsen FL; Crosby SD; Ramanan N; Efimova T
J Invest Dermatol; 2013 Mar; 133(3):608-617. PubMed ID: 23151848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
